CFDs are complex instruments. You can lose your money rapidly due to leverage. Please ensure you understand how this product works and whether you can afford to take the high risk of losing money. CFDs are complex instruments. You can lose your money rapidly due to leverage. Please ensure you understand how this product works and whether you can afford to take the high risk of losing money.

ASX 200 surges 219 points as new coronavirus cases slow

We examine some of the key market moves and analyst updates from Monday, 6 April.

With news emerging that the spread of the novel coronavirus in Australia has begun to slow, financial markets reacted in an unsurprisingly bullish manner today.

Specifically, the ASX 200 finished out the day at the 5286 point level – up some 219 points or 4.33%.

At the time of writing, Australia’s coronavirus case count stood at 5,788; while total deaths stemming from the virus have reached 39. Positively, some 2,315 individuals have reportedly recovered from the virus.

ASX 200 market news and developments

As bullishness again returns, all sectors managed to finish out the day higher. This change in mood comes after the ASX 200 dropped 1.68% on Friday.

Energy stocks were the best performing here, with the ASX 200 Energy Index (XEJ) finishing out the day up 5.70%; followed by the A-REIT Index (XXJ), which gained 4.79%; and the Financial Index (XFJ), which added 4.72% and finished out the day at 4,302 points.

By comparison, the Industrials sector was the worst performing of the day, with the XNJ index closing out Monday up ‘just’ 2.25% – at the 4,951 point level.

On a more granular level, Corporate Travel Management, Pilbara Minerals and HUB24 were Australia's best performing equities; while Webjet, NextDC and IDP Education were the worst performing.

Looking at some of Monday's other key developments: Flight Centre announced that it was gearing up for a $700 million equity raise; Oil Search was placed in a trading halt pending news concerning its own capital raise; antimicrobial micro-cap Zoono revealed a strong up-tick in Q3 sales; Seek announced it would be deferring its Interim Dividend; Origin Energy provided an operational and financial update to the market; and Paradigm Biopharma joined a growing list of companies set to tap the market for fresh capital.

Upgrades, downgrades and everything in between

Elsewhere, Macquarie Wealth Management lowered its price target on outdoor retailer Kathmandu to $0.98 per share (from $1.57 per share); Morgan Stanley argued that Afterpay may be set to benefit from Covid-19 induced 'online tailwinds', though the investment bank retained its Equal-weight rating and $19.00 per share price target; JP Morgan prophetically flagged Oil Search’s 'debt metrics' as stretched; Bell Potter upgraded its recommendation on Suncorp from Hold to Accumulate; and Citibank lowered its price target on Ramsay Health Care from $75.00 per share to $70.00 per share – though retained its Buy recommendation.

How to trade markets – long or short

What do you make of today’s bullish price action: Is it sustainable or not? Whatever your opinion, you can trade indices, currencies and equities – both up and down – through IG’s trading platform now.

For example, to buy (long) or sell (short) the ASX 200 using CFDs, follow these easy steps:

  • Create an IG Trading Account or log in to your existing account
  • Enter ‘Australia 200’ or ‘ASX 200’ in the search bar and select it
  • Choose your position size
  • Click on ‘buy’ or ‘sell’ in the deal ticket
  • Confirm the trade

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.